In vitro and in vivo interaction of AtRma2 E3 ubiquitin ligase and auxin binding protein 1
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 손오라 | - |
dc.contributor.author | 김우택 | - |
dc.contributor.author | 김수진 | - |
dc.contributor.author | 조석근 | - |
dc.date.available | 2021-02-22T13:48:24Z | - |
dc.date.issued | 2010-03 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.issn | 1090-2104 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/13243 | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Academic Press | - |
dc.title | In vitro and in vivo interaction of AtRma2 E3 ubiquitin ligase and auxin binding protein 1 | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1016/j.bbrc.2010.02.032 | - |
dc.identifier.scopusid | 2-s2.0-77949264238 | - |
dc.identifier.wosid | 000275978400028 | - |
dc.identifier.bibliographicCitation | Biochemical and Biophysical Research Communications, v.393, no.3, pp 492 - 497 | - |
dc.citation.title | Biochemical and Biophysical Research Communications | - |
dc.citation.volume | 393 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 492 | - |
dc.citation.endPage | 497 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/abs/pii/S0006291X10002433?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.